NCT00505921 Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma Status TERMINATED Phase PHASE2
NCT00505245 New Assessment System in Measuring Symptom Distress in Cancer Patients Status RECRUITING Phase N/A
NCT00504491 R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia Status WITHDRAWN Phase PHASE2
NCT00502359 Testing Ascensia Contour Glucometer for the Measurement of Blood Glucose Status COMPLETED Phase N/A
NCT00501059 A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease Status COMPLETED Phase PHASE3
NCT00499343 G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients Status COMPLETED Phase PHASE2
NCT00498784 HR-QoL and Sexuality in Mirena Inserted Contraception Users Status COMPLETED Phase PHASE4
NCT00496756 Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer Status TERMINATED Phase PHASE2
NCT00496379 ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases Status TERMINATED Phase PHASE2
NCT00494871 Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation Status COMPLETED Phase PHASE3
NCT00494299 Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE) Status COMPLETED Phase PHASE3
NCT00493038 Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis Status TERMINATED Phase PHASE4
NCT00492986 An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE3
NCT00492752 A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT00492726 Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem Status COMPLETED Phase PHASE3
NCT00492635 Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED Status COMPLETED Phase PHASE3
NCT00492297 A Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00488241 Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema Status COMPLETED Phase PHASE4